GENMAB AS
For the period ended Dec 31, 2023. Filed Feb 14, 2024.
View on SEC.govAbout this filing
The yearly report of a company based outside the US. It covers much of what a 10-K does, and may follow accounting rules other than US ones.
FY2023 · Filed Feb 14, 2024
GMAB$53.63+1.7%Stored close · as of Nov 6, 2026
Opening this filing…